Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Exanthema × Dapsone × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pneumonia, Pneumocystis 1 Leukoplakia, Oral 1 HIV Infections 1 Exanthema 1 Carcinoma, Non-Small-Cell Lung 1 Candidiasis, Oral 1 AIDS-Related Opportunistic Infections 1 AIDS-Related Complex 1

Interventions

Sirolimus 1 Panitumumab 1 Irinotecan 1 IFL protocol 1 Gels 1 Doxycycline 1 Dapsone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00343187 2011-05-30

A Phase II Study of ACZONE™ (Dapsone) Gel, 5% As a Treatment For Tarceva® (Erlotinib)Related Rash

Allergan

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung, Exanthema

Data powered by HemOnc (CC BY 4.0) Colophon ⚡